Recent Press Releases & News
VTVT earnings at a glance
vTv Therapeutics Inc. (VTVT) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of -$1.07, compared with -$1.08 in the same quarter last year (+1%). Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±5.9% on average; after the most recent report on Aug 6, 2026 it moved +2.2%. VTVT beat the consensus EPS estimate in 2 of its last 6 reported quarters. The share price of $25.55 sits in the middle of its 52-week range.
Overview
Earnings trends
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu Aug 6, 2026 | 8K 2026-08-06 | $-1.05 | $-0.75 | -40.0% | — | +2.2% | earnings |
| Wed May 13, 2026 | Mar/2026 | $1.65 | $0.34 | +385.3% | +314.3% | +21.4% | earnings |
| Tue Mar 10, 2026 | 8K 2026-03-10 | $-0.58 | $-0.98 | +40.8% | — | +0.2% | earnings |
| Thu Nov 6, 2025 | Sep/2025 | $-1.08 | $-0.97 | -11.3% | — | +2.2% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.92 | $-0.85 | -8.2% | — | -3.2% | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.77 | $-0.73 | -5.5% | — | -6.2% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Nov 5, 2026 | Sep/2026 | OTHER | -$1.07 | -$1.08 | +0.9% |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $37M | — | $0 | $0 | $0 | — | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-14M | $23M | — | $-11M | $-8M | $-7M | — | $-7M |
| Net income | $-13M | $24M | — | $-9M | $-6M | $-5M | — | $-5M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $87M | $98M | $89M | $99M | $26M | $31M | $37M | $42M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $88M | $99M | $90M | $99M | $26M | $32M | $38M | $43M |
| Total assets | $88M | $99M | $90M | $99M | $26M | $32M | $38M | $43M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $9M | $9M | $25M | $29M | $24M | $23M | $24M | $25M |
| Total equity | $79M | $90M | $64M | $71M | $2M | $9M | $12M | $18M |
Implied volatility — last 90 days
No IV snapshots yet for VTVT.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
VTVT earnings FAQ
When is VTVT's next earnings date?
vTv Therapeutics Inc. is expected to report on November 5, 2026.
How does VTVT stock usually react to earnings?
Across the last 6 reports the average next-day move was ±5.9%, up 4 times and down 2 times.
What EPS are analysts expecting from vTv Therapeutics Inc.?
The consensus estimate is -$1.07 per share, versus -$1.08 a year ago.